The new Phase 1 clinic that recently opened at Smilow Cancer Hospital is the only one of its kind in Connecticut. It will provide essential options for patients with advanced cancers seeking new therapies when standard treatments are no longer an option. Many phase I trials are offered with new targeted therapies that have been proved effective in research, others test new combinations of approved therapies and new applications. In collaboration with Yale Cancer Center, Smilow Cancer Hospital currently has over 40 phase I clinical trials available to patients.
"With this new center, we are seeing the true integration of science and clinical research," said Rogerio Lilenbaum, chief medical officer, Smilow Cancer Hospital. "This is a true clinical research unit where innovation and cutting-edge research meet to offer patients new hope and new treatment strategies that otherwise might not be available to them."
Clinical trials are research studies that test how well new medical approaches work in people. Each study answers scientific questions and tries to find better ways to prevent, screen for, diagnose or treat a disease. People who take part in cancer clinical trials have an opportunity to contribute to knowledge of, and progress against, cancer. They also receive up-to-date care from experts.
MONET: New AI tool enhances medical imaging with deep learning and text analysis